Smoore International Releases 2024 ESG Report with Innovations Update

Apr.14
Smoore International Releases 2024 ESG Report with Innovations Update
Smoore International releases 2024 ESG report, showcasing R&D investment and technological innovations in the electronic vaping industry.

Recently, Smoore International Holdings Limited (06969.HK, "Smoore International") released its "2024 Environmental, Social and Governance Report". The report contains information on the company's annual progress in product and technology innovation. Data from the report shows that Smoore invested approximately 1.57 billion RMB in research and development in 2024, with 1609 R&D personnel. The company has established a research and development system including research institutes, technology centers, product development teams, and technology industrialization centers.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance Report

 

The report by Firsts found new developments in the field of electronic atomization technology in the year 2024.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG Report Content | Image Source: 2024 Environmental, Social, and Governance Report.

 

FEELM technology platform: POWER ALPHA 2.0 version supports over 15,000 puffs, with a battery energy density reportedly increased by 40% and a 70% reduction in self-discharge rate. 

The FEELM Turbo ceramic core solution is said to increase flavor intensity by 200%, vapor production by 80%, and puff count by over 30%. 

FEELM Pro brings two different series of high puff count solutions: the TPD compliant 5000 puff solution TANKER and the TPD compliant 3200 puff four-in-one solution QUAD SHOT Pro.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance Report

 

VAPORESSO, a self-owned brand, has launched the XROS, LUXE, ECO, and ARMOUR series products. The company has also introduced the VIBE product platform, with a focus on providing a similar taste and ease of use as disposable products, along with stylish design. 

 

The taste emphasizes delicacy, richness, and consistency; ease of use emphasizes large capacity, adjustability, easy pod replacement, and strong battery life; the design style aims for a young and trendy look, incorporating integrated design and screen display technology. 

 

The report notes that VAPORESSO products have won several awards, including the MUSE Design Award, London Design Award, IDA International Design Award, French Bilateral Design Award, German Design Award, and International CMF Design Award.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance report

 

In other areas of atomization applications, the report disclosed the following information:

 

HNB (Heated Tobacco Product)/Hybrid/e-cigarette product: The MiEE product combines heating tobacco and vaporization functions, using plant extract technology that is compatible with over 80% of heating sticks. The report states that this product reduces harmful organic compounds by 1.97 times compared to other HTP products, improves performance by 30%, and increases nicotine delivery by 50%.

 

Moyal launched its MOYAL Rain brand in 2024, featuring TPS transdermal technology to aerosolize high-viscosity essence for skin penetration. The product line includes both consumer and professional-grade devices (2B+2C). 

 

In the field of aerosolized medicine, its subsidiary Transpire Bio completed the introduction of inhalation devices for asthma and COPD, with key indicators meeting European and American regulatory requirements. Collaborations with international pharmaceutical companies have been established to advance the development of integrated medications with inhalation delivery devices (2B+2C). 

 

The report also highlights an iF Design Award-winning cartridge-based product, utilizing 100% tobacco extract and incorporating a rotating pop-up hygienic mouthpiece.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
PouchEx Stockholm 2025 — Where the Future of Oral Innovation Begins
PouchEx Stockholm 2025 — Where the Future of Oral Innovation Begins
PouchEx Stockholm 2025 is coming to Sweden, bringing together leading brands, technologies, and thought leaders to explore the future of smoke-free innovation. It will be one of the must-attend nicotine pouch events of 2025. 2Firsts is one of the official media partners of the event.
Oct.11
Kazakh Man Fined $146 for Illegal Sale of e-cigarettes in Uralsk
Kazakh Man Fined $146 for Illegal Sale of e-cigarettes in Uralsk
A man in Ural'sk, Kazakhstan, was fined 78,640 tenge (about 146 US dollars) for illegal e-cigarette sales. The police took swift action after the case was exposed.
Aug.22 by 2FIRSTS.ai
Russia plans to introduce a bill to crack down on e-cigarette sales, with individual fines of up to $20,000
Russia plans to introduce a bill to crack down on e-cigarette sales, with individual fines of up to $20,000
Russia is preparing a bill to crack down on the sale of e-cigarettes. The bill would impose fines of up to 200,000 rubles (approximately $2,406) for the retail and wholesale sale of e-cigarettes, with fines of up to 2 million rubles (approximately $20,000) for businesses. The bill aims to fill gaps in the definition of e-cigarettes in existing laws and curb their popularity among youth to protect public health.
Sep.17 by 2FIRSTS.ai
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International’s U.S. affiliate (PMI America) has released a new white paper stating that U.S. healthcare professionals hold serious misconceptions about smoke-free products, with nearly half incorrectly believing that nicotine causes cancer. As a result, smokers are being denied scientifically accurate harm-reduction advice. The report calls on the U.S. Food and Drug Administration (FDA) to deliver accurate information on smoke-free alternatives to physicians, so they can help adul
Aug.19 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai